Markets › United States › NAS › CLDX

Celldex Therapeutics Inc

NAS:CLDXHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$29.02+0.17%LiveIn session · ≈ AED 106.58 · Market cap $2.28B · Next earnings Mon 9 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	−473.4%	−1,046.2%	−3,389.9%	−1,614.5%	−2,229.8%	100.0%	—	—
Operating margin	−854.1%	−1,531.8%	−4,889.0%	−2,245.3%	−2,778.9%	−19,160.0%	−19,160.0%	+0.0 pts
Net margin	−805.9%	−1,516.0%	−4,765.6%	−2,054.8%	−2,248.8%	−17,253.3%	−17,250.5%	+2.9 pts
EBITDA margin	−615.3%	−1,420.8%	−4,420.9%	−2,020.0%	−2,203.5%	−17,028.0%	—	—
Return on equity	−28.6%	−16.8%	−34.4%	−33.0%	−21.1%	−49.1%	−49.1%	+0.0 pts
Return on assets	−25.3%	−15.9%	−31.8%	−30.4%	−19.9%	−44.4%	−44.4%	+0.0 pts
Return on capital employed	−28.6%	−16.6%	−34.5%	−35.6%	−25.9%	−54.0%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	1.5%	0.7%	1.1%	0.5%	0.5%	0.4%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	13.9×	24.9×	17.1×	13.9×	18.9×	10.5×	10.5×	+0.0%
Quick ratio	13.9×	24.9×	17.1×	13.9×	18.9×	10.5×	—	—
Cash ratio	3.1×	2.4×	1.6×	1.1×	0.7×	0.6×	0.6×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	4.1×	27.0×	6.8×	1.5×	10.0×	0.7×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—